Efficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy Switch

Clinical trial NCT04892654 · RECRUITING

Trial details

NCT number: NCT04892654
Sponsor: Chelsea and Westminster NHS Foundation Trust
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

HIV-1-infection

Start date: 2022-08-17
Primary completion: 2026-11-30
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.